Richard A. Young

Filings by Richard A. Young span 3 companies, the busiest being Omega Therapeutics, Inc., Syros Pharmaceuticals, Inc. and Camp4 Therapeutics Corp. Between 14 September 2022 and 3 August 2026, the trades on record add up to 14 filings.

Both buying and selling appear: 2 purchases worth €45k, against 7 sales worth €415k. No amount is published for 1 filing, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 2 share grants and 2 option exercises. 2026 to date brings 1 purchase and no sales.

The newest entry dates from 5 August 2026: an open-market purchase of €23k, in Camp4 Therapeutics Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.